TCL Archive House-Senate conferees Decide On $733.5 Million (Plus Training Funds) For NCI In 1976 October 31, 1975
TCL Archive ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention January 10, 1997
TCL Archive Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL July 11, 2014